High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors.

High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors.
复制标题

DOI:
10.1016/j.vaccine.2012.03.079
复制
发表时间:
2012-06-06
期刊:
影响因子:
5.5
通讯作者:
Srivastava, Arun
Srivastava, Arun
中科院分区:
医学3区
文献类型:
--
作者:
Aslanidi, George V.;Rivers, Angela E.;Ortiz, Luis;Govindasamy, Lakshmanan;Ling, Chen;Jayandharan, Giridhara R.;Zolotukhin, Sergei;Agbandje-McKenna, Mavis;Srivastava, Arun

文献摘要

参考文献

被引文献

相似文献

Phosphorylation of surface-exposed tyrosine residues negatively impacts the transduction efficiency of recombinant AAV2 vectors. Pre-treatment of cells with specific cellular serine/threonine kinase inhibitors also significantly increased the transduction efficiency of AAV2 vectors. We reasoned that site-directed mutagenesis of surface-exposed serine residues might allow the vectors to evade phosphorylation and thus lead to higher transduction efficiency. Each of the 15 surface-exposed serine (S) residues was substituted with valine (V) residues, and the transduction efficiency of three of these mutants, S458V, S492Vand S662V, was increased by up to∼20-fold in different cell types. The S662V mutant was efficient in transducing human monocyte-derived dendritic cells (moDCs), a cell type not readily amenable to transduction by the conventional AAV vectors, and did not induce any phenotypic changes in these cells. Recombinant S662V-AAV2 vectors encoding a truncated human telomerase (hTERT) gene were generated and used to stimulate cytotoxic T cells (CTLs) against target cells. S662V-AAV2-hTERT vector-transduced DCs resulted in rapid, specific T-cell clone proliferation and generation of robust CTLs, which led to specific cell lysis of K562 cells. These studies suggest that high-efficiency transduction of moDCs by serine-modified AAV2 vectors is feasible, which supports the potential utility of these vectors for future human DC vaccine studies.
DOI: 10.1007/s00262-007-0307-2
发表时间: 2007-10-01
影响因子: 5.8
作者:
Mahadevan, Mahendran;Liu, Yong;Hermonat, Paul L.
通讯作者: Hermonat, Paul L.
DOI: 10.1073/pnas.0810614106
发表时间: 2009-03-31
影响因子: 11.1
作者:
Aslanidi, George;Lamb, Kenneth;Zolotukhin, Sergei
通讯作者: Zolotukhin, Sergei
DOI: 10.1038/mt.2008.269
发表时间: 2009-03-01
期刊: MOLECULAR THERAPY
影响因子: 12.4
作者:
Petrs-Silva, Hilda;Dinculescu, Astra;Hauswirth, William W.
通讯作者: Hauswirth, William W.
DOI: 10.1128/jvi.80.2.821-834.2006
发表时间: 2006-01-01
影响因子: 5.4
作者:
Lochrie, MA;Tatsuno, GP;Colosi, P
通讯作者: Colosi, P
DOI: 10.1038/nm1039
发表时间: 2004-05-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Figdor, CG;de Vries, IJM;Melief, CJM
通讯作者: Melief, CJM